To determine if nitroxoline treatment inhibits CD11b+Gr-1+MDSC in C3H/He tumor-bearing mice, mice were treated by gavage with nitroxoline or PBS as a control five times a week on days 1, 2, 4, 5, 7, 8, 10 and 11. Here, ITGAM is linked to neoplasm.